Caregen Co., Ltd. (KOSDAQ:214370)
65,400
+200 (0.31%)
Sep 18, 2025, 12:40 PM KST
Caregen Revenue
Caregen had revenue of 18.12B KRW in the quarter ending June 30, 2025, a decrease of -11.46%. This brings the company's revenue in the last twelve months to 81.08B, up 5.21% year-over-year. In the year 2024, Caregen had annual revenue of 82.59B with 4.26% growth.
Revenue (ttm)
81.08B
Revenue Growth
+5.21%
P/S Ratio
39.30
Revenue / Employee
420.13M
Employees
193
Market Cap
3,186.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82.59B | 3.38B | 4.26% |
Dec 31, 2023 | 79.21B | 10.11B | 14.63% |
Dec 31, 2022 | 69.10B | 10.01B | 16.94% |
Dec 31, 2021 | 59.09B | -1.21B | -2.00% |
Dec 31, 2020 | 60.30B | -4.40B | -6.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |
Caregen News
- 10 months ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 10 months ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn